Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 28Leukemia, Myeloid, Acute 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Leukemia 23Lymphoma 22Small Cell Lung Carcinoma 20Burkitt Lymphoma 19Lymphoma, Non-Hodgkin 18Lung Neoplasms 13Recurrence 12Neuroblastoma 12Lymphoma, Mantle-Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 12Congenital Abnormalities 12Myelodysplastic Syndromes 11Lymphoma, Follicular 11Brain Neoplasms 10Hodgkin Disease 9Carcinoma, Non-Small-Cell Lung 9Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Accelerated Phase 8Leukemia, Monocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Blast Crisis 8Sarcoma 7Neoplasms 7Myeloproliferative Disorders 7Multiple Myeloma 7

Interventions

Vincristine 2Topotecan 2Stem Cell Transplantation 2Radiation 2Platinum 2Melphalan 2Doxorubicin 2Cyclophosphamide 2Congresses as Topic 2Cisplatin 2Busulfan 21,2-diaminocyclohexaneplatinum II citrate 2etoposide phosphate 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Isotretinoin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Ganglioneuroblastoma × Etoposide × Clear all
NCT01798004 2024-07-15

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Children's Oncology Group

Phase 1 Completed
150 enrolled 9 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡